Aqua Bounty Technologies, Inc. AQB
We take great care to ensure that the data presented and summarized in this overview for AquaBounty Technologies, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AQB
View allLatest Institutional Activity in AQB
Top Purchases
Top Sells
About AQB
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
Insider Transactions at AQB
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2023
|
Rick L. Sterling Director |
BUY
Grant, award, or other acquisition
|
Direct |
55,555
+49.42%
|
-
|
|
Jun 14
2023
|
Michael K Stern Director |
BUY
Grant, award, or other acquisition
|
Direct |
55,555
+38.02%
|
-
|
|
Jun 14
2023
|
Gail Sharps Myers Director |
BUY
Grant, award, or other acquisition
|
Direct |
55,555
+45.71%
|
-
|
|
Jun 14
2023
|
Christine St.Clare Director |
BUY
Grant, award, or other acquisition
|
Direct |
55,555
+46.08%
|
-
|
|
Jun 14
2023
|
Erin S Sharp Director |
BUY
Grant, award, or other acquisition
|
Direct |
55,555
+22.9%
|
-
|
|
Jun 14
2023
|
Ricardo J Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
55,555
+45.87%
|
-
|
|
Mar 09
2023
|
Angela M Olsen General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
44,423
+33.19%
|
-
|
|
Mar 09
2023
|
Sylvia Wulf CEO & Director |
BUY
Grant, award, or other acquisition
|
Direct |
73,462
+19.31%
|
-
|
|
Mar 09
2023
|
David A Frank Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,247
+25.87%
|
-
|
|
Mar 09
2023
|
Alejandro Rojas Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,130
+39.86%
|
-
|
|
Dec 23
2022
|
Gail Sharps Myers Director |
BUY
Open market or private purchase
|
Direct |
10,000
+48.96%
|
$0
$0.89 P/Share
|
|
Dec 22
2022
|
Gail Sharps Myers Director |
BUY
Open market or private purchase
|
Direct |
1
+0.23%
|
$0
$0.85 P/Share
|
|
Dec 20
2022
|
Christine St.Clare Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$0
$0.78 P/Share
|
|
Dec 19
2022
|
Erin S Sharp Director |
BUY
Open market or private purchase
|
Direct |
131,500
+50.0%
|
$0
$0.75 P/Share
|
|
Dec 16
2022
|
Michael K Stern Director |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$0
$0.74 P/Share
|
|
Dec 16
2022
|
Ricardo J Alvarez Director |
BUY
Open market or private purchase
|
Direct |
2,084
+50.0%
|
$0
$0.74 P/Share
|
|
Dec 15
2022
|
Sylvia Wulf CEO & Director |
BUY
Open market or private purchase
|
Direct |
8,903
+50.0%
|
$0
$0.69 P/Share
|
|
Dec 15
2022
|
Ricardo J Alvarez Director |
BUY
Open market or private purchase
|
Direct |
3,871
+50.0%
|
$0
$0.72 P/Share
|
|
Dec 14
2022
|
Sylvia Wulf CEO & Director |
BUY
Open market or private purchase
|
Direct |
1,097
+50.0%
|
$0
$0.65 P/Share
|
|
Dec 14
2022
|
Ricardo J Alvarez Director |
BUY
Open market or private purchase
|
Direct |
4,045
+50.0%
|
$0
$0.66 P/Share
|